SyntheX Funding
Investors of SyntheX
Startup investor interested in all sectors, all stages, all geos. Investments in biotech, tech, and space.
8VC
$640M Fund (Seed, Series A, Series B, Follow-On)
Jason is the Managing Director & Chief Medical Officer at Thiel Capital.
We run the startup development programs HAX, IndieBio, Chinaccelerator, MOX, and dlab
